The HinduLean L·
Piramal Pharma to acquire remaining 26% stake in Yapan Bio
With the acquisition, Piramal will fully embed Yapan’s advanced large molecule capabilities into its integrated service offering
Read at The Hindu →
With the acquisition, Piramal will fully embed Yapan’s advanced large molecule capabilities into its integrated service offering
<iframe src="https://hindustansphere.com/embed/cluster/afc1209c7fd4d05c63e9839da440c62bdacf6137" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="Piramal Pharma to acquire remaining 26% stake in Yapan Bio"></iframe>